Review



mrsa strain mw2  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 95
      Buy from Supplier

    Structured Review

    ATCC mrsa strain mw2
    Mrsa Strain Mw2, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 132 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mrsa+strain+mw2/us12594296-651-4-7?v=ATCC
    Average 95 stars, based on 132 article reviews
    mrsa strain mw2 - by Bioz Stars, 2026-07
    95/100 stars

    Images



    Similar Products

    mrsa strain mw2  (ATCC)
    95
    ATCC mrsa strain mw2
    Mrsa Strain Mw2, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mrsa+strain+mw2/us12594296-651-4-7?v=ATCC
    Average 95 stars, based on 1 article reviews
    mrsa strain mw2 - by Bioz Stars, 2026-07
    95/100 stars
    		  Buy from Supplier
    mrsa strain nrs123 (mw2)  (BEI Resources)
    90
    BEI Resources mrsa strain nrs123 (mw2)
    Mrsa Strain Nrs123 (Mw2), supplied by BEI Resources, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mrsa+strain+mw2/pm37561151-39-26-23?v=BEI+Resources
    Average 90 stars, based on 1 article reviews
    mrsa strain nrs123 (mw2) - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    s aureus mrsa strain mw2 baa 1707  (ATCC)
    95
    ATCC s aureus mrsa strain mw2 baa 1707
    S Aureus Mrsa Strain Mw2 Baa 1707, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mrsa+strain+mw2/us11707442-682-66-98?v=ATCC
    Average 95 stars, based on 1 article reviews
    s aureus mrsa strain mw2 baa 1707 - by Bioz Stars, 2026-07
    95/100 stars
    		  Buy from Supplier
    ntzdpa against major pathogenic bacteria bacterial strains ntzdpa van1 oxa2 gm3 cipro4 s aureus mrsa mw2  (ATCC)
    93
    ATCC ntzdpa against major pathogenic bacteria bacterial strains ntzdpa van1 oxa2 gm3 cipro4 s aureus mrsa mw2
    Ntzdpa Against Major Pathogenic Bacteria Bacterial Strains Ntzdpa Van1 Oxa2 Gm3 Cipro4 S Aureus Mrsa Mw2, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mrsa+strain+mw2/us11690824-653-7-47?v=ATCC
    Average 93 stars, based on 1 article reviews
    ntzdpa against major pathogenic bacteria bacterial strains ntzdpa van1 oxa2 gm3 cipro4 s aureus mrsa mw2 - by Bioz Stars, 2026-07
    93/100 stars
    		  Buy from Supplier
    atcc29213 laboratory reference strain american type culture collection mw2 ca mrsa  (ATCC)
    99
    ATCC atcc29213 laboratory reference strain american type culture collection mw2 ca mrsa
    Atcc29213 Laboratory Reference Strain American Type Culture Collection Mw2 Ca Mrsa, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mrsa+strain+mw2/pm37237805-58-10-14?v=ATCC
    Average 99 stars, based on 1 article reviews
    atcc29213 laboratory reference strain american type culture collection mw2 ca mrsa - by Bioz Stars, 2026-07
    99/100 stars
    		  Buy from Supplier
    s. aureus mrsa strain mw2 (nrs123)  (BEI Resources)
    90
    BEI Resources s. aureus mrsa strain mw2 (nrs123)
    S. Aureus Mrsa Strain Mw2 (Nrs123), supplied by BEI Resources, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mrsa+strain+mw2/pm36862002-91-1-24?v=BEI+Resources
    Average 90 stars, based on 1 article reviews
    s. aureus mrsa strain mw2 (nrs123) - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    exebacase mic values against mrsa strain mw2  (ATCC)
    99
    ATCC exebacase mic values against mrsa strain mw2
    MICs of <t> exebacase </t> and antibiotics against S. aureus strains
    Exebacase Mic Values Against Mrsa Strain Mw2, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mrsa+strain+mw2/pmc10100934-26-2-12?v=ATCC
    Average 99 stars, based on 1 article reviews
    exebacase mic values against mrsa strain mw2 - by Bioz Stars, 2026-07
    99/100 stars
    		  Buy from Supplier
    exeba case mic values against mrsa strain mw2  (ATCC)
    99
    ATCC exeba case mic values against mrsa strain mw2
    MICs of <t> exebacase </t> and antibiotics against S. aureus strains
    Exeba Case Mic Values Against Mrsa Strain Mw2, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mrsa+strain+mw2/pm36862002-41-2-13?v=ATCC
    Average 99 stars, based on 1 article reviews
    exeba case mic values against mrsa strain mw2 - by Bioz Stars, 2026-07
    99/100 stars
    		  Buy from Supplier

    Image Search Results


    MICs of exebacase and antibiotics against S. aureus strains

    Journal: Microbiology Spectrum

    Article Title: The Lysin Exebacase Has a Low Propensity for Resistance Development in Staphylococcus aureus and Suppresses the Emergence of Resistance to Antistaphylococcal Antibiotics

    doi: 10.1128/spectrum.05261-22

    Figure Lengend Snippet: MICs of exebacase and antibiotics against S. aureus strains

    Article Snippet: Antibiotic and exebacase MIC values against MRSA strain MW2 and MSSA strain ATCC 29213 were determined as described in CLSI standard M07-A11 ( ) as well as in CAMHB-HSD medium.

    Techniques:

    Serial passage of MSSA strain ATCC 29213 over 28 days with exebacase or oxacillin. (A) Log 2 changes in exebacase MICs for three replicate cultures treated with exebacase and the untreated control in CAMHB-HSD. (B) Log 2 changes in oxacillin MICs for three replicate cultures treated with oxacillin and the untreated passage control in CAMHB. Closed triangles, circles, and squares, three replicate treatments; open squares, untreated control.

    Journal: Microbiology Spectrum

    Article Title: The Lysin Exebacase Has a Low Propensity for Resistance Development in Staphylococcus aureus and Suppresses the Emergence of Resistance to Antistaphylococcal Antibiotics

    doi: 10.1128/spectrum.05261-22

    Figure Lengend Snippet: Serial passage of MSSA strain ATCC 29213 over 28 days with exebacase or oxacillin. (A) Log 2 changes in exebacase MICs for three replicate cultures treated with exebacase and the untreated control in CAMHB-HSD. (B) Log 2 changes in oxacillin MICs for three replicate cultures treated with oxacillin and the untreated passage control in CAMHB. Closed triangles, circles, and squares, three replicate treatments; open squares, untreated control.

    Article Snippet: Antibiotic and exebacase MIC values against MRSA strain MW2 and MSSA strain ATCC 29213 were determined as described in CLSI standard M07-A11 ( ) as well as in CAMHB-HSD medium.

    Techniques: Control

    Serial passage of MRSA strain MW2 over 28 days with exebacase, daptomycin, or vancomycin. (A) Log 2 changes in exebacase MICs for three replicate cultures treated with exebacase and the untreated control in CAMHB-HSD. (B) Log 2 changes in daptomycin MICs for three replicate cultures treated with daptomycin and the untreated control in CAMHB (+CaCl 2 ). (C) Log 2 changes in vancomycin MICs for three replicate cultures treated with vancomycin and the untreated control in CAMHB. Closed triangles, circles, and squares, three replicate treatments; open squares, untreated control.

    Journal: Microbiology Spectrum

    Article Title: The Lysin Exebacase Has a Low Propensity for Resistance Development in Staphylococcus aureus and Suppresses the Emergence of Resistance to Antistaphylococcal Antibiotics

    doi: 10.1128/spectrum.05261-22

    Figure Lengend Snippet: Serial passage of MRSA strain MW2 over 28 days with exebacase, daptomycin, or vancomycin. (A) Log 2 changes in exebacase MICs for three replicate cultures treated with exebacase and the untreated control in CAMHB-HSD. (B) Log 2 changes in daptomycin MICs for three replicate cultures treated with daptomycin and the untreated control in CAMHB (+CaCl 2 ). (C) Log 2 changes in vancomycin MICs for three replicate cultures treated with vancomycin and the untreated control in CAMHB. Closed triangles, circles, and squares, three replicate treatments; open squares, untreated control.

    Article Snippet: Antibiotic and exebacase MIC values against MRSA strain MW2 and MSSA strain ATCC 29213 were determined as described in CLSI standard M07-A11 ( ) as well as in CAMHB-HSD medium.

    Techniques: Control

    Oxacillin MICs through serial passage of MSSA strain ATCC 29213 over 28 days in CAMHB-HSD with oxacillin alone and in addition to sub-MIC exebacase. (A) Three replicate cultures treated with oxacillin alone and untreated control. (B) Three replicate cultures treated with oxacillin in addition to 1/16 of the MIC of exebacase (0.03 μg/mL). A control passaged only with sub-MIC exebacase is included. (C) Three replicate cultures treated with oxacillin in addition to 1/32 of the MIC of exebacase (0.015 μg/mL). A control passaged only with sub-MIC exebacase is included. (D) Three replicate cultures treated with oxacillin in addition to 1/64 of the MIC of exebacase (0.0075 μg/mL). A control passaged only with sub-MIC exebacase is included. Closed triangles, circles, and squares, three replicate treatments with oxacillin alone (A) or in addition to exebacase (B to D); open squares, untreated control (for oxacillin alone [A]) or exebacase alone (for combination passages [B to D]).

    Journal: Microbiology Spectrum

    Article Title: The Lysin Exebacase Has a Low Propensity for Resistance Development in Staphylococcus aureus and Suppresses the Emergence of Resistance to Antistaphylococcal Antibiotics

    doi: 10.1128/spectrum.05261-22

    Figure Lengend Snippet: Oxacillin MICs through serial passage of MSSA strain ATCC 29213 over 28 days in CAMHB-HSD with oxacillin alone and in addition to sub-MIC exebacase. (A) Three replicate cultures treated with oxacillin alone and untreated control. (B) Three replicate cultures treated with oxacillin in addition to 1/16 of the MIC of exebacase (0.03 μg/mL). A control passaged only with sub-MIC exebacase is included. (C) Three replicate cultures treated with oxacillin in addition to 1/32 of the MIC of exebacase (0.015 μg/mL). A control passaged only with sub-MIC exebacase is included. (D) Three replicate cultures treated with oxacillin in addition to 1/64 of the MIC of exebacase (0.0075 μg/mL). A control passaged only with sub-MIC exebacase is included. Closed triangles, circles, and squares, three replicate treatments with oxacillin alone (A) or in addition to exebacase (B to D); open squares, untreated control (for oxacillin alone [A]) or exebacase alone (for combination passages [B to D]).

    Article Snippet: Antibiotic and exebacase MIC values against MRSA strain MW2 and MSSA strain ATCC 29213 were determined as described in CLSI standard M07-A11 ( ) as well as in CAMHB-HSD medium.

    Techniques: Control

    Daptomycin MICs through serial passage of MSSA strain ATCC 29213 over 28 days in CAMHB-HSD with daptomycin alone and in addition to sub-MIC exebacase. (A) Three replicate cultures treated with daptomycin alone and an untreated control. (B) Three replicate cultures treated with daptomycin in addition to 1/16 of the MIC of exebacase (0.03 μg/mL). A control passaged only with sub-MIC exebacase is included. (C) Three replicate cultures treated with daptomycin in addition to 1/32 of the MIC of exebacase (0.015 μg/mL). A control passaged only with sub-MIC exebacase is included. (D) Three replicate cultures treated with daptomycin in addition to 1/64 of the MIC of exebacase (0.0075 μg/mL). A control passaged only with sub-MIC exebacase is included. Closed triangles, circles, and squares, three replicate treatments with daptomycin alone (A) or in addition to exebacase (B to D); open squares, untreated control (for daptomycin alone [A]) or exebacase alone (for combination passages [B to D]).

    Journal: Microbiology Spectrum

    Article Title: The Lysin Exebacase Has a Low Propensity for Resistance Development in Staphylococcus aureus and Suppresses the Emergence of Resistance to Antistaphylococcal Antibiotics

    doi: 10.1128/spectrum.05261-22

    Figure Lengend Snippet: Daptomycin MICs through serial passage of MSSA strain ATCC 29213 over 28 days in CAMHB-HSD with daptomycin alone and in addition to sub-MIC exebacase. (A) Three replicate cultures treated with daptomycin alone and an untreated control. (B) Three replicate cultures treated with daptomycin in addition to 1/16 of the MIC of exebacase (0.03 μg/mL). A control passaged only with sub-MIC exebacase is included. (C) Three replicate cultures treated with daptomycin in addition to 1/32 of the MIC of exebacase (0.015 μg/mL). A control passaged only with sub-MIC exebacase is included. (D) Three replicate cultures treated with daptomycin in addition to 1/64 of the MIC of exebacase (0.0075 μg/mL). A control passaged only with sub-MIC exebacase is included. Closed triangles, circles, and squares, three replicate treatments with daptomycin alone (A) or in addition to exebacase (B to D); open squares, untreated control (for daptomycin alone [A]) or exebacase alone (for combination passages [B to D]).

    Article Snippet: Antibiotic and exebacase MIC values against MRSA strain MW2 and MSSA strain ATCC 29213 were determined as described in CLSI standard M07-A11 ( ) as well as in CAMHB-HSD medium.

    Techniques: Control

    Vancomycin MICs through serial passage of MSSA strain ATCC 29213 over 28 days in CAMHB-HSD with vancomycin alone and in addition to sub-MIC exebacase. (A) Three replicate cultures treated with vancomycin alone and an untreated control. (B) Three replicate cultures treated with vancomycin in addition to 1/16 of the MIC of exebacase (0.03 μg/mL). A control passaged only with sub-MIC exebacase is included. (C) Three replicate cultures treated with vancomycin in addition to 1/32 of the MIC of exebacase (0.015 μg/mL). A control passaged only with sub-MIC exebacase is included. (D) Three replicate cultures treated with vancomycin in addition to 1/64 of the MIC of exebacase (0.0075 μg/mL). A control passaged only with sub-MIC exebacase is included. Closed triangles, circles, and squares, three replicate treatments with vancomycin alone (A) or in addition to exebacase (B to D); open squares, untreated control (for vancomycin alone [A]) or exebacase alone (for combination passages [B to D]).

    Journal: Microbiology Spectrum

    Article Title: The Lysin Exebacase Has a Low Propensity for Resistance Development in Staphylococcus aureus and Suppresses the Emergence of Resistance to Antistaphylococcal Antibiotics

    doi: 10.1128/spectrum.05261-22

    Figure Lengend Snippet: Vancomycin MICs through serial passage of MSSA strain ATCC 29213 over 28 days in CAMHB-HSD with vancomycin alone and in addition to sub-MIC exebacase. (A) Three replicate cultures treated with vancomycin alone and an untreated control. (B) Three replicate cultures treated with vancomycin in addition to 1/16 of the MIC of exebacase (0.03 μg/mL). A control passaged only with sub-MIC exebacase is included. (C) Three replicate cultures treated with vancomycin in addition to 1/32 of the MIC of exebacase (0.015 μg/mL). A control passaged only with sub-MIC exebacase is included. (D) Three replicate cultures treated with vancomycin in addition to 1/64 of the MIC of exebacase (0.0075 μg/mL). A control passaged only with sub-MIC exebacase is included. Closed triangles, circles, and squares, three replicate treatments with vancomycin alone (A) or in addition to exebacase (B to D); open squares, untreated control (for vancomycin alone [A]) or exebacase alone (for combination passages [B to D]).

    Article Snippet: Antibiotic and exebacase MIC values against MRSA strain MW2 and MSSA strain ATCC 29213 were determined as described in CLSI standard M07-A11 ( ) as well as in CAMHB-HSD medium.

    Techniques: Control